TransWorldNews Current Releases http://www.transworldnews.com TransWorldNews Bringing Your News to the World Copyright TransWorldNews, Inc. RSSEngine 1.0.0.3 Tue, 21 May 2013 13:15:34 GMT 15 Current Releases http://www.transworldnews.com/images/twn_logo.gif http://www.transworldnews.com Nutrition 21 Receives Commitment from Rite Aid Corporation for its Chromax(R) Product; First Time Chromax Brand To Be Sold in Retail Stores Nutrition 21, Inc., (NASDAQ: NXXI) today announced that it has received a purchase order from Rite Aid Corporation for the Company's Chromax(R) chromium picolinate product. Rite Aid will distribute Chromax chain-wide at its 3,400 plus stores. Thi ... http://www.transworldnews.com/NewsStory.aspx?storyid=4593 http://www.transworldnews.com/NewsStory.aspx?storyid=4593 Fri, 13 Jan 2006 18:57:58 GMT Nutrition 21 Appoints Dean DiMaria to Vice President of Sales and Marketing Nutrition 21, Inc., (NASDAQ: NXXI) the leading developer and marketer of chromium-based nutritional supplements, today announced the appointment of Dean DiMaria as the Companys Vice President of Sales and Marketing. http://www.transworldnews.com/NewsStory.aspx?storyid=5441 http://www.transworldnews.com/NewsStory.aspx?storyid=5441 Tue, 13 Dec 2005 05:00:00 GMT Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax(R) Chromium Picolinate Inclusion in FiberChoice(R) Weight Management Chewable Tablets Nutrition 21, Inc., (NASDAQ: NXXI) today announced a supply & licensing agreement with CNS, Inc, the Breathe Right * company, for the exclusive use of Chromax chromium picolinate as an ingredient in CNS' newest product in the FiberChoice * fra ... http://www.transworldnews.com/NewsStory.aspx?storyid=5442 http://www.transworldnews.com/NewsStory.aspx?storyid=5442 Mon, 31 Oct 2005 05:00:00 GMT NEW STUDY PUBLISHED IN LEADING TOXICOLOGY JOURNAL CONCLUDES CHROMAX CHROMIUM PICOLINATE IS SAFE Nutrition 21, Inc., (NASDAQ: NXXI) today announced results of a new study that found Chromax chromium picolinate does not produce chromosomal aberrations in Chinese Hamster Ovary (CHO) cells. http://www.transworldnews.com/NewsStory.aspx?storyid=5443 http://www.transworldnews.com/NewsStory.aspx?storyid=5443 Mon, 24 Oct 2005 05:00:00 GMT Chromium Picolinate Linked With Reduced Carbohydrate Cravings In People With Atypical Depression A randomized, double-blind, placebo-controlled study assessing chromium picolinate supplementation in 113 people with atypical depression found that a subset of patients who reported the highest levels of carbohydrate cravings demonstrated signif ... http://www.transworldnews.com/NewsStory.aspx?storyid=5444 http://www.transworldnews.com/NewsStory.aspx?storyid=5444 Thu, 29 Sep 2005 05:00:00 GMT Nutrition 21 Reports Fiscal Fourth-Quarter And Full-Year 2005 Results Nutrition 21, Inc. (NASDAQ: NXXI), the leading developer and marketer of chromium-based nutritional supplements, today announced financial results for the fourth quarter and fiscal year ended June 30, 2005. http://www.transworldnews.com/NewsStory.aspx?storyid=5445 http://www.transworldnews.com/NewsStory.aspx?storyid=5445 Tue, 27 Sep 2005 05:00:00 GMT Study Results Show Diachrome Improves Poorly-Controlled Blood Sugar Levels for People on Antidiabetic Prescription Medications Nutrition 21 (NASDAQ: NXXI) A sub-set analysis from a Diachrome XLHealth clinical trial demonstrates that adding daily supplementation with Diachrome to prescription treatment regimens can significantly improve glycemic control in poorly contro ... http://www.transworldnews.com/NewsStory.aspx?storyid=5446 http://www.transworldnews.com/NewsStory.aspx?storyid=5446 Mon, 12 Sep 2005 22:00:00 GMT Nutrition 21 and Dong Sung Pharmaceuticals Enter into Distribution Agreement for Chromax and Diachrome Nutrition 21, Inc. (Nasdaq: NXXI), the leading developer and marketer of chromium-based nutritional supplements, announced today that it has entered into an exclusive distribution agreement with Dong Sung Pharmaceuticals Co. Ltd., a leading Seoul ... http://www.transworldnews.com/NewsStory.aspx?storyid=5447 http://www.transworldnews.com/NewsStory.aspx?storyid=5447 Thu, 08 Sep 2005 05:00:00 GMT Diachrome Supplementation Associated with Potential Cost Savings of $52.9 Billion for People with Diabetes Nutrition 21, Inc. (Nasdaq: NXXI) reported that an economic analysis conducted by researchers in the Department of Health Policy at Thomas Jefferson University in Philadelphia shows that use of Diachrome, as a daily nutritional adjunct to traditi ... http://www.transworldnews.com/NewsStory.aspx?storyid=5448 http://www.transworldnews.com/NewsStory.aspx?storyid=5448 Wed, 31 Aug 2005 05:00:00 GMT FDA APPROVES FIRST QUALIFIED HEALTH CLAIM FOR CHROMIUM PICOLINATE AND RISK OF TYPE 2 DIABETES The U.S. Food & Drug Administration (FDA) issued a favorable response to a qualified health claim petition filed by Nutrition 21, recognizing chromium picolinate as a safe nutritional supplement that may reduce the risk of insulin resistance and ... http://www.transworldnews.com/NewsStory.aspx?storyid=5449 http://www.transworldnews.com/NewsStory.aspx?storyid=5449 Mon, 29 Aug 2005 05:00:00 GMT Nutrition 21 Receives Widespread Approval in Europe for the Continued Sale of Chromax Chromium Picolinate and Zinmax Zinc Picolinate Nutrition 21, Inc., (NASDAQ: NXXI) the leading developer and marketer of chromium-based nutritional supplements, today announced that it has received derogation (approval for continued sale) in more than 17 member states within the European Uni ... http://www.transworldnews.com/NewsStory.aspx?storyid=5450 http://www.transworldnews.com/NewsStory.aspx?storyid=5450 Tue, 02 Aug 2005 05:00:00 GMT